EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysregulation of astrocytic Ca2+ signaling and gliotransmitter release in mouse models of α-synucleinopathies

Carmen Nanclares, Jonah Poynter, Hector A Martell-Martinez, Scott Vermilyea, Alfonso Araque, Paulo Kofuji, Michael K Lee, Ana Covelo iD

Acta Neuropathologica · 2023

DOI: 10.1007/s00401-023-02547-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2023. Verfasst von Carmen Nanclares und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Minnesota, 4-125 Jackson Hall, 321 Church Street SE, Minneapolis, MN, 55455, USA. Hauptthemen laut MEDLINE: Synucleinopathies, Parkinson Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-Synuclein is a major component of Lewy bodies (LB) and Lewy neurites (LN) appearing in the postmortem brain of Parkinson's disease (PD) and other α-synucleinopathies. While most studies of α-synucleinopathies have focused on neuronal and synaptic alterations as well as dysfunctions of the astrocytic homeostatic roles, whether the bidirectional astrocyte–neuronal communication is affected in these diseases remains unknown. We have investigated whether the astrocyte Ca 2+ excitability and the glutamatergic gliotransmission underlying astrocyte–neuronal signaling are altered in several transgenic mouse models related to α-synucleinopathies, i.e., mice expressing high and low levels of the human A53T mutant α-synuclein (G2-3 and H5 mice, respectively) globally or selectively in neurons (iSyn mice), mice expressing human wildtype α-synuclein (I2-2 mice), and mice expressing A30P mutant α-synuclein (O2 mice). Combining astrocytic Ca 2+ imaging and neuronal electrophysiological recordings in hippocampal slices of these mice, we have found that compared to non-transgenic mice, astrocytes in G2-3 mice at different ages (1–6 months) displayed a Ca 2+ hyperexcitability that was independent of neurotransmitter receptor activation, suggesting that the expression of α-synuclein mutant A53T altered the intrinsic properties of astrocytes. Similar dysregulation of the astrocyte Ca 2+ signal was present in H5 mice, but not in I2-2 and O2 mice, indicating α-synuclein mutant-specific effects. Moreover, astrocyte Ca 2+ hyperexcitability was absent in mice expressing the α-synuclein mutant A53T selectively in neurons, indicating that the effects on astrocytes were cell-autonomous. Consistent with these effects, glutamatergic gliotransmission was enhanced in G2-3 and H5 mice, but was unaffected in I2-2, O2 and iSyn mice. These results indicate a cell-autonomous effect of pathogenic A53T expression in astrocytes that may contribute to the altered neuronal and synaptic function observed in α-synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynucleinopathiesParkinson DiseaseMiceHumansAnimalsalpha-SynucleinAstrocytesMice, TransgenicDisease Models, Animal

Stichwörter der Autor:innen

AstrocyteCalciumGliotransmissionSynucleinopathiesα-synuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neuroscience, University of Minnesota, 4-125 Jackson Hall, 321 Church Street SE, Minneapolis, MN, 55455, USA.
  • Institute for Translational Neuroscience, University of Minnesota, 2101 6th Street SE, Minneapolis, MN, 55455, USA.
  • Department of Neuroscience, University of Minnesota, 4-125 Jackson Hall, 321 Church Street SE, Minneapolis, MN, 55455, USA. kofuj001@umn.edu.
  • Department of Neuroscience, University of Minnesota, 4-125 Jackson Hall, 321 Church Street SE, Minneapolis, MN, 55455, USA. mklee@umn.edu.
  • Institute for Translational Neuroscience, University of Minnesota, 2101 6th Street SE, Minneapolis, MN, 55455, USA. mklee@umn.edu.
  • Department of Neuroscience, University of Minnesota, 4-125 Jackson Hall, 321 Church Street SE, Minneapolis, MN, 55455, USA. ana.covelo@inserm.fr.

ORCID-Profile: Ana Covelo

Förderung

  • NIMH NIH HHS
  • NINDS NIH HHS
  • NIA NIH HHS
  • NIDA NIH HHS
  • NIH-MH
  • NIH-NINDS
  • NIH-NIDA
  • NIH-NIA

Zitieren

APA

Nanclares, C., Poynter, J., Martell-Martinez, H. A., Vermilyea, S., Araque, A., Kofuji, P., Lee, M. K., & Covelo, A. (2023). Dysregulation of astrocytic Ca2+ signaling and gliotransmitter release in mouse models of α-synucleinopathies. Acta Neuropathologica. https://doi.org/10.1007/s00401-023-02547-3

Vancouver

Nanclares C, Poynter J, Martell-Martinez HA, Vermilyea S, Araque A, Kofuji P, et al. Dysregulation of astrocytic Ca2+ signaling and gliotransmitter release in mouse models of α-synucleinopathies. Acta Neuropathologica. 2023. doi:10.1007/s00401-023-02547-3

BibTeX
@article{Nanclares2023,
  author = {Nanclares, Carmen and Poynter, Jonah and Martell-Martinez, Hector A and Vermilyea, Scott and Araque, Alfonso and Kofuji, Paulo and Lee, Michael K and Covelo, Ana},
  title = {Dysregulation of astrocytic Ca2+ signaling and gliotransmitter release in mouse models of α-synucleinopathies},
  journal = {Acta Neuropathologica},
  year = {2023},
  doi = {10.1007/s00401-023-02547-3}
}
Kostenlos starten →